NMR Relative Valuation
NMR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NMR is overvalued; if below, it's undervalued.
Historical Valuation
Nomura Holdings Inc (NMR) is now in the Undervalued zone, suggesting that its current forward PE ratio of 7.82 is considered Undervalued compared with the five-year average of 10.55. The fair price of Nomura Holdings Inc (NMR) is between 6.50 to 13.95 according to relative valuation methord. Compared to the current price of 6.17 USD , Nomura Holdings Inc is Undervalued By 5.11%.
Relative Value
Fair Zone
6.50-13.95
Current Price：6.17
5.11%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.77
P/B
Median3y
0.64
Median5y
0.62
-32.25
FCF Yield
Median3y
-40.76
Median5y
-28.26
Competitors Valuation Multiple
The average P/S ratio for NMR's competitors is 6.74, providing a benchmark for relative valuation. Nomura Holdings Inc Corp (NMR) exhibits a P/S ratio of 1.52, which is -77.52% above the industry average. Given its robust revenue growth of -10.41%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Nomura Holdings Inc (NMR) currently overvalued or undervalued?
What is Nomura Holdings Inc (NMR) fair value?
How does NMR's valuation metrics compare to the industry average?
What is the current P/B ratio for Nomura Holdings Inc (NMR) as of Jun 16 2025?
What is the current FCF Yield for Nomura Holdings Inc (NMR) as of Jun 16 2025?
What is the current Forward P/E ratio for Nomura Holdings Inc (NMR) as of Jun 16 2025?